\
&
Contact us
\
&
Contact us
This was 9 months ago
LocationEuropean Convention Center Luxembourg
Space4defence, the European Defence Fund Industry & Matchmaking Day 2025 will take place on the 26th of February 2025, in the European Convention Center Luxembourg, in Luxembourg.
This matchmaking day will bring together innovative startups, SMEs, research organisations and large companies interested in and eligible to apply to the calls for proposals of the European Defence Fund (EDF).
The aim is to help them connect with partners who have specific expertise or solutions, form consortia, and spark new ideas through collaborative meetings.
Participants will be able to present their solutions and explore collaboration opportunities within the space domain in view of the EDF 2025 calls for proposals. Startups and SMEs will have the opportunity to pitch their companies and solutions.
You can find more information and register yourself here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
